dépression

New use for an old drug: How does ketamine combat depression?

Published: 16Dec2020

A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian...

Strong social support decreases mental health problems in young adults

Published: 4Dec2020

Early adulthood, a transitional life stage marked by major changes in social roles and responsibilities, can bring with it an increase of mental health problems. A team of McGill University...

Promising advance in depression research

Published: 8Apr2020

Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes....

A new molecular target identified in depression

Published: 7May2018

The discovery of a new mechanism involved in depression – and a way to target it with a drug as effective as classical antidepressants -- provides new understanding of this illness and could pave...

Flawed research methods exaggerate the prevalence of depression

Published: 18Jan2018

An over-reliance on self-report screening questionnaires, wherein patients essentially define their own condition, in place of diagnostic interviews conducted by a health care professional, has...

Speeding up SSRIs

Published: 3Aug2017

For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have...

Depression screening in children and adolescents

Published: 2Aug2016

McGill Newsroom Researchers find tools inaccurate and advise against routine screening in this age group

Pages

Back to top